Sökning: onr:"swepub:oai:DiVA.org:uu-151831" > Challenges and oppo...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02738naa a2200565 4500 | |
001 | oai:DiVA.org:uu-151831 | |
003 | SwePub | |
008 | 110418s2010 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1518312 URI |
024 | 7 | a https://doi.org/10.1016/j.clinthera.2010.09.0142 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Chen, Mei-Ling4 aut |
245 | 1 0 | a Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products :b Workshop summary report. |
264 | 1 | b Elsevier BV,c 2010 |
338 | a print2 rdacarrier | |
520 | a The current regulatory approaches and criteria for bioequivalence evaluation were considered adequate for the assessment of therapeutic equivalence and interchangeability of conventional monophasic MR products. Additional measures may occasionally be needed to establish the bioequivalence of multiphasic MR products, and development of such measures is an important objective. The metric of partial AUC was proposed for products designed to have a rapid drug action followed by sustained response. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
653 | a PHARMACY | |
653 | a FARMACI | |
700 | 1 | a Shah, Vinod P4 aut |
700 | 1 | a Ganes, Derek4 aut |
700 | 1 | a Midha, Kamal K4 aut |
700 | 1 | a Caro, James4 aut |
700 | 1 | a Nambiar, Prabu4 aut |
700 | 1 | a Rocci, Mario L4 aut |
700 | 1 | a Thombre, Avinash G4 aut |
700 | 1 | a Abrahamsson, Bertilu Uppsala universitet,Institutionen för farmaci4 aut0 (Swepub:uu)berab705 |
700 | 1 | a Conner, Dale4 aut |
700 | 1 | a Davit, Barbara4 aut |
700 | 1 | a Fackler, Paul4 aut |
700 | 1 | a Farrell, Colm4 aut |
700 | 1 | a Gupta, Suneel4 aut |
700 | 1 | a Katz, Russell4 aut |
700 | 1 | a Mehta, Mehul4 aut |
700 | 1 | a Preskorn, Sheldon H4 aut |
700 | 1 | a Sanderink, Gerard4 aut |
700 | 1 | a Stavchansky, Salomon4 aut |
700 | 1 | a Temple, Robert4 aut |
700 | 1 | a Wang, Yaning4 aut |
700 | 1 | a Winkle, Helen4 aut |
700 | 1 | a Yu, Lawrence4 aut |
710 | 2 | a Uppsala universitetb Institutionen för farmaci4 org |
773 | 0 | t Clinical Therapeuticsd : Elsevier BVg 32:10, s. 1704-1712q 32:10<1704-1712x 0149-2918x 1879-114X |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-151831 |
856 | 4 8 | u https://doi.org/10.1016/j.clinthera.2010.09.014 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy